Trial · NCT02236247
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
NCT02236247, Phase 1, Phase 2, Unknown, University of Sao Paulo
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure. Trials, record NCT02236247. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02236247
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
- NCT number
- NCT02236247
- Status
- Unknown
- Phases
- Phase 1, Phase 2
- Enrollment
- 50 participants, estimated
- Lead sponsor
- University of Sao Paulo
- Conditions
- Decompensated Heart Failure
- Interventions
- ivabradine, Placebo
- First posted
- 2014-09-10
- Last updated
- 2017-01-02
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline heart rate | Baseline, day 5 after intervention | Heart rate will be assessed at morning, after 30 minutes of rest, recorded by electrocardiogram. |
| Secondary | Change from baseline blood pressure | Baseline, day 5 after intervention | Blood pressure will be measured at morning by electronic cuff |
| Secondary | Change from baseline ejection fraction | Baseline, day 5 after intervention | Ejection fraction will be measured by echocardiography using Simpson´s rule |
| Secondary | Change from baseline stroke volume | Baseline, day 5 after intervention | Stroke volume will be measured by echocardiography using Doppler velocity-time integral technique. |
| Secondary | Change from baseline creatinine | Baseline, day 5 after intervention | Serum creatinine will be measured |
| Secondary | Change from baseline brain natriuretic peptide | Baseline, day 5 after intervention | Serum brain natriuretic peptide will be measured |
| Secondary | Clinical | Up to 6 months | Time of survival and free of readmission |
| Other | Safety/Adverse Event Outcome Measure | Up to day 15 days after intervention | Number of Participants with Serious and Non-Serious Adverse Events |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 27469019 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02236247
GET https://conductscience.org/api/trials/v1/NCT02236247/registered